rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5342
|
pubmed:dateCreated |
1997-12-16
|
pubmed:abstractText |
Virus-specific CD4+ T helper lymphocytes are critical to the maintenance of effective immunity in a number of chronic viral infections, but are characteristically undetectable in chronic human immunodeficiency virus-type 1 (HIV-1) infection. In individuals who control viremia in the absence of antiviral therapy, polyclonal, persistent, and vigorous HIV-1-specific CD4+ T cell proliferative responses were present, resulting in the elaboration of interferon-gamma and antiviral beta chemokines. In persons with chronic infection, HIV-1-specific proliferative responses to p24 were inversely related to viral load. Strong HIV-1-specific proliferative responses were also detected following treatment of acutely infected persons with potent antiviral therapy. The HIV-1-specific helper cells are likely to be important in immunotherapeutic interventions and vaccine development.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0036-8075
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
278
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1447-50
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9367954-Amino Acid Sequence,
pubmed-meshheading:9367954-Anti-HIV Agents,
pubmed-meshheading:9367954-Chemokines,
pubmed-meshheading:9367954-Cohort Studies,
pubmed-meshheading:9367954-Cytotoxicity, Immunologic,
pubmed-meshheading:9367954-Disease Progression,
pubmed-meshheading:9367954-Drug Therapy, Combination,
pubmed-meshheading:9367954-HIV Core Protein p24,
pubmed-meshheading:9367954-HIV Envelope Protein gp160,
pubmed-meshheading:9367954-HIV Infections,
pubmed-meshheading:9367954-HIV-1,
pubmed-meshheading:9367954-Humans,
pubmed-meshheading:9367954-Immunologic Memory,
pubmed-meshheading:9367954-Interferon-gamma,
pubmed-meshheading:9367954-Lymphocyte Activation,
pubmed-meshheading:9367954-Molecular Sequence Data,
pubmed-meshheading:9367954-Peptide Fragments,
pubmed-meshheading:9367954-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:9367954-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:9367954-Viral Load,
pubmed-meshheading:9367954-Viremia,
pubmed-meshheading:9367954-Virus Replication
|
pubmed:year |
1997
|
pubmed:articleTitle |
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
|
pubmed:affiliation |
Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|